Systematic Review ARTICLE
Systematic Review: Overlap Between Eating, Autism Spectrum, and Attention-Deficit/Hyperactivity Disorder
- 1Section for Experimental Neuropsychiatry, Department of Psychiatry and Psychotherapy, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 2Department of Psychosomatic Medicine and Psychotherapy, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 3Department of Psychotherapeutic Neurology, Kliniken Schmieder, Gailingen, Germany
Background: Links between eating disorders (EDs) [e.g., anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED)] and the major neurodevelopmental disorders of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) have been repeatedly highlighted. In both ASD and ADHD, these links range from an elevated risk for EDs to common symptomatic overlaps and etiological commonalities with EDs.
Methods: We performed a systematic literature search (through July 2019) with Medline via Ovid for epidemiological data on EDs (AN, BN, and BED) in combination with both ASD and ADHD.
Results: The reviewed studies showed that, on average, 4.7% of patients with certain ED diagnoses (AN, BN, or BED) received an ASD diagnosis. Reliable data on the prevalence of EDs in ASD samples are still scarce. Comorbid ASD is most commonly diagnosed in patients with AN. The prevalence of ADHD in EDs ranged between 1.6% and 18%. Comorbid ADHD was more often reported in the AN-binge eating/purging subtype and BN than in the AN restrictive subtype. The prevalence of EDs in ADHD ranged between no association and a lifetime prevalence of 21.8% of developing an ED in women with ADHD.
Conclusions: Studies on the prevalence rates of EDs in ADHD and ASD and vice versa are heterogeneous, but they indicate frequent association. While there is growing evidence of clinical overlaps between the three disorders, it remains difficult to determine whether overlapping characteristics (e.g., social withdrawal) are due to common comorbidities (e.g., depression) or are instead primarily associated with EDs and neurodevelopmental disorders. Furthermore, prospective studies are required to better understand how these disorders are related and whether ADHD and ASD could be either specific or nonspecific predisposing factors for the development of EDs.
The exact relationship and overlap between eating disorders (EDs) [e.g., anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED)] and neurodevelopmental disorders (NDDs), such as autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), as defined in DSM-5, remain unclear. The core pathological features of AN are a persistent restriction of energy intake and/or purging behavior, an intense fear of weight gain, as well as a disturbance in the self-perception of one’s body shape. BN is characterized by binge eating episodes and inappropriate compensatory behaviors (1). BED, which was newly approved for inclusion in the DSM-5, is defined by recurrent episodes of binge eating associated with guilt, disgust, and marked distress but without compensatory behavior (1). Notably, in both the DSM-5 and the ICD-11, further eating and feeding disorders [pica, rumination disorder, and avoidant/restrictive food disorder (ARFID)] were included in the same chapter. Pica and ARFID usually occur in infancy and early childhood. In contrast to AN and BN, they are not associated with concerns about body weight and shape. AN and BN typically manifest during adolescence, and they are strongly tied to maturation processes during later developmental phases (2).
ASD is a pervasive NDD with an onset in early childhood that is characterized by deficits in social communication and interaction combined with restrictive, repetitive patterns of behavior and/or interests. The presence of symptoms in an early developmental period is mandatory for diagnosis. ADHD, another common NDD, also manifests during infancy. The core symptoms of ADHD include attention deficits, hyperactivity, and impulsiveness (1). Many patients show symptoms of both ASD and ADHD; therefore, a dual diagnosis per the DSM-5 is possible (1). ASD and ADHD are the most prominent examples of childhood onset neuropsychiatric disorders (3). Symptomatic overlaps between ADHD and ASD have been reported in terms of hyperactivity, irritability, social impairment, and inattentiveness (4, 5). The diagnosis of ASD is often delayed, and children are sometimes initially misdiagnosed with ADHD due to its symptoms being present in both disorders (6). It is well recognized that ASD and ADHD may be the bases for the later development of secondary psychiatric complications, such as anxiety and depression (7); however, their roles in the development of EDs have not yet been discussed in depth.
To date, several studies have either addressed the prevalence of certain EDs (AN, BN, and BED) in ASD and ADHD samples or vice versa or have analyzed the symptomatic overlap between these disorders. Overlapping features between EDs (predominantly AN) and ASD comprise repetitive and restricted behavior, social withdrawal, and difficulties in understanding another’s mental state (8). ADHD shares symptomatic overlap with EDs, especially BN, in terms of impulsive behavior and disturbed reward encoding, which lead to altered motivational control and attentional biases (9).
Some studies have shown associations between ARFID, pica, and ASD (10, 11), but ASD and ADHD in EDs have mainly been investigated separately from each other. However, some studies have examined all three disorders and reported shared traits between them (12, 13).
While the association between ADHD and ASD is not the focus of this review, the relationship between these two diseases and EDs is systematically reviewed.
To answer the research question, we performed a systematic literature review by focusing on prevalence rates of ASD and ADHD in AN, BN, and BED and vice versa. In this review, we did not focus on ARFID, pica, and rumination disorder.
Based on studies that addressed either symptomatic, developmental, or genetic differences and commonalities between NDDs and EDs, our specific objective was to clarify the following question: How common are AN, BN, and BED in ASD and ADHD samples and vice versa?
We conducted a Medline search via Ovid [Ovid MEDLINE® Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE® Daily, and Ovid MEDLINE® (1946 to 07/13/2019)] and searched for epidemiological data on specific EDs (AN, BN, and BED) in ASD and ADHD. The exact search strategy is presented in Table 1. The search was carried out on July 13, 2019.
We included data on the prevalence of AN, BN, and BED in ASD and ADHD and vice versa.
The inclusion criteria were defined as follows: The application of valid instruments to confirm the ED/ASD diagnosis was mandatory. EDs and ASD were diagnosed per either the Structured Clinical Interview for DSM Axis I Disorders (SCID-I), ICD-8, ICD-9, ICD-10, DSM-III-R, DSM-IV, or DSM-5. Additionally, we separately investigated studies that had applied the Autism Diagnostic Observation Schedule, (ADOS-2) questionnaire for the ASD diagnostic process (14). The ADOS-2 (14) is a semi-structured assessment for ASD and is the most widely used and best-validated direct observational measure of ASD characteristics (15). Studies that either only focused on certain autistic traits, applied questionnaires other than the ADOS-2 (14) or the Developmental Diagnostic Dimensional Interview—short version (3Di-sv) (16), or did not receive a clinical diagnosis per the criteria mentioned earlier were not considered.
In the analysis of the prevalence rate of ADHD in the ED samples and vice versa, only studies in which the ED diagnosis was established per either the SCID-I, ICD-8, ICD-9, ICD-10, DSM-III-R, DSM-IV, DSM-5, or Kiddie Schedule for Affective Disorders and Schizophrenia (17) were included. ADHD had to have been diagnosed per either the SCID-I, ICD-8, ICD-9, ICD-10, DSM-III-R, DSM-IV, DSM-5, DISC-IV (18), or Kiddie Schedule for Affective Disorders and Schizophrenia (17). Additionally, studies that investigated symptoms of childhood ADHD by applying the Wender Utah Rating Scale (19) were considered separately. Studies that focused only on specific ADHD traits or primarily on obesity and not the EDs listed earlier were excluded.
Other eligibility criteria included being published in a peer-reviewed journal and being available in English. Case reports were not considered. Figure 1 illustrates the selection of the studies in a PRISMA flow diagram.
Autism Spectrum Disorder and Eating Disorders
A total of 139 studies (AN, BN, BED, and ASD) were identified in the Medline search, of which 13 met the inclusion criteria (3, 12, 20–30). We additionally screened the three detected meta-analyses (31–33) carefully for further studies. Huke et al. (31) concentrated on EDs and ASD, which were diagnosed per either the DSM-III-R or DSM-IV or the upcoming DSM-5 or ICD-10 criteria. Westwood et al. focused on ASD traits in EDs per either the Autism Spectrum Quotient (32) or other investigative tools (e.g., the ADOS-2, 3Di-sv, or Ritvo Autism Asperger Diagnostic Scale—Revised) (33). From the reviews, we included four additional studies (34–37), which provided a total of 17 studies for analysis.
Table 2 lists the results of the systematic literature search for a) ASD in EDs and b) EDs in ASD. The majority of the studies that investigated ASD in EDs focused on AN participants (20, 22–24, 26, 27, 29, 30, 34, 36, 37), while only a few included mixed ED samples (3, 25, 28, 35). The previous studies had mainly examined female participants, with six including only women (3, 26, 29, 30, 34, 35). Some studies primarily focused on adolescents (20, 25, 26, 28, 29, 34, 37), while others included mainly adults (3, 22, 24, 27, 30, 35, 36). Five studies were based on the same Swedish community sample; therefore, to calculate the prevalence rate, we only considered the average prevalence rate of all five studies (16.0%) (20, 22, 24, 36, 37) to avoid biasing effects.
The reviewed studies showed that, on average, 26.5% [with the exclusion of the preselected sample study (35) 25.4%] of the ED patients scored above the cutoff of the ADOS-2 (26, 29, 30, 34, 35) indicating the presence of important ASD symptoms.
On average, 4.7% of the ED (AN, BN, and BED) patients received an ASD diagnosis per either the DSM-III-R, DSM-IV, DSM-5, or ADOS-2 (14) in combination with the 3Di-sv (16) (3, 20, 22–25, 28, 29, 36, 37). Because most of the reviewed studies focused on AN, we calculated the prevalence rates for this diagnostic category separately. When including only AN participants, the prevalence rate was also 4.7% diagnosed with ASD (20, 22–24, 27, 29, 36, 37).
Literature focusing on EDs in ASD samples is scarce. Karjalainen et al. (12) investigated a sample of 228 adults with an ADHD and/or an ASD diagnosis. For the entire sample, 7.9% had either a current or a previous ED. AN predominantly occurred in ASD (6.7% of ASD patients with an AN diagnosis), while BED was more often diagnosed within the ADHD group (6.4%). A Danish nationwide register-based cohort study showed that participants with a first diagnosis of ASD have an elevated risk of having a second diagnosis of AN (HR = 5.3). However, the risk of comorbid ASD did not differ from the risk of comorbid major depression in AN probands, and it was proposed to be nonspecific (23). Bölte et al. (21) analyzed 103 patients with ASD and found that 28% of male individuals had a body mass index in either the fifth percentile or below. However, the results indicated that the link was inconsistent and partly mediated by hyperactivity (21).
Attention-Deficit/Hyperactivity Disorder and Eating Disorders
A total of 252 studies (AN, BN, BED, and ADHD) were initially identified, of which 16 met the inclusion criteria (3, 12, 51–64). Additionally, we screened the three detected meta-analyses (9, 65, 66) and included nine further studies (9, 65–75).
Table 3 presents the results of the systematic literature search for a) ADHD in EDs and b) EDs in ADHD.
The prevalence of ADHD in EDs ranged between 1.6% (62) and 18.0% (59). Comorbid ADHD was more often reported in patients with the AN-binge eating/purging subtype than in the AN restrictive subtype (3, 59, 63). Most of the previous investigations included mixed ED samples (AN, BN, and BED). Only one study included exclusively patients with BED (73), and it found that 1.7% of BED cases had comorbid ADHD. Two studies focused only on participants with BN (60, 71), and they reported that, on average, 22.5% of patients with BN met the clinical cutoff of the Wender Utah Rating Scale questionnaire (76), indicating previous childhood ADHD.
Available studies that have focused on the prevalence of EDs in ADHD are heterogeneous, and their results have varied from no association between EDs and ADHD (54, 58, 68), an association between EDs and ADHD (odds ratio = 16.1) (70), an increased lifetime risk of developing an ED in the ADHD group (51, 52, 64, 69), and a lifetime prevalence of 21.8% of developing an ED in women with ADHD (55).
Overlap Between Eating Disorders and Autism Spectrum Disorder
A previous systematic review (31) reported increased prevalence rates of ASD in ED populations in comparison with those in healthy controls. The average ASD prevalence of the reviewed studies was 22.9% (31). Importantly, six of the eight considered studies were based on the same Swedish community sample, which could have biased the results and led to the high prevalence rate of ASD in EDs. Huke et al. (31) chose a less stringent definition of the ASD diagnosis, which included patients with “empathy disorder” and histories that were suggestive of high-functioning autism. In our systematic review, we included four additional investigations (23, 25, 28, 29) and detected a lower prevalence rate with, on average, a 4.7% rate of patients with an ED (AN, BN, and BED) or with AN receiving an ASD diagnosis.
The different diagnostic tools (register-based data, clinical diagnosis, various investigation tools), study samples, and methodologies that were used make it difficult to compare the studies and determine the exact prevalence rate of ASD in EDs. Furthermore, diagnostic criteria have changed over the years due to the different versions of the ICD and the DSM. For example, in the DSM-5, autistic disorder, disintegrative disorder in childhood, and Asperger’s syndrome were dimensionally subsumed to ASD. Additionally, the DSM-5 criteria revised AN (e.g., significantly low body weight was newly defined) and BN (e.g., the frequency of binge eating and compensatory behaviors was reduced to weekly), and BED was officially recognized as a formal diagnosis and as the third ED entity (93).
Studies suggest an overrepresentation of ASD in EDs, especially in AN. However, the overlap of EDs with ASD that was found in our study was less than it was with other mental disorders [e.g., 31–89% of patients with AN suffer from depression (94), and 15–69% suffer from obsessive-compulsive disorder (95)]. Furthermore, >50% of ED patients are diagnosed with an anxiety disorder (96). This might properly reflect lower base rates of ASD compared with, for example, depression.
Per the Centers for Disease Control and Prevention, 1 in 59 children (∼1.7%) has been identified with ASD in the general population (https://www.cdc.gov/ncbddd/autism/data.html; retrieval date July 14, 2019). We calculated the prevalence rate as 4.7% of patients with an ED being diagnosed with ASD, which exceeds the prevalence rate for ASD in the general population.
Studies that have investigated the prevalence rates of EDs in ASD samples are scarce and quite heterogeneous; therefore, they are not directly comparable due to the differing investigative tools, age groups, and sample compositions. In particular, because EDs usually occur later in life than ASD and ADHD do, the included children’s studies can only provide information about the ED prevalence rates of their respective age groups.
Associations between EDs and ASD have already been proposed based on clinical observations by Gillberg (97). It has been assumed that autistic impairments might represent a risk factor for both the onset and persistence of EDs (8). One can speculate that social impairments, as they occur with ASD, can lead to reduced social feedback about the disease’s condition as well as special challenges in the therapy, which could result in ED persistence. Stereotypical eating behavior and gustatory, olfactory hypersensitivity may also favor unusual eating habits. Previous research has described overlapping features of EDs and ASD.
An important area of symptom overlap between EDs and ASD concerns impaired neurocognitive functioning. This includes weak central coherence (the ability to see the “big picture” rather than the details), impaired set shifting (the ability to shift from one approach to another fluently and with little difficulty), and difficulties in theory of mind tasks (the ability to attribute mental states) (31, 98, 99). Most studies in EDs have focused on patients with AN. Comparable with individuals with ASD, the weak central coherence in AN is accompanied by a more detail-oriented, so-called “local processing” style and leads to missing the overarching meaning of a situation (8, 100). Weak central coherence is likely a key factor in the shift toward systematized interests in ASD (101). Weak central coherence in AN is most pronounced during the acute state of illness and might also facilitate the shift and restriction of interests but lack the “developmental history” of an onset during early childhood as in ASD. Additionally, executive dysfunction has been reported in EDs, especially in patients with AN and BN (102) as well as in ASD (103). Overall, and because of a lack of longitudinal studies, it is unclear whether neurocognitive deficits are either a risk factor for or a consequence of EDs (98).
Poor theory of mind in AN, however, seems to be limited to the acute state of AN, which could be a consequence of starvation (104). Both disorders show increased social anxiety (105, 106), which is possibly due to difficulties in theory of mind. Social anhedonia (107, 108) and alexithymia (109) have also been described in both, AN and ASD. Again, in AN, what are indeed predisposing characteristics versus what are consequences of the disease have yet to be clarified.
Eating disturbances, such as avoidance of certain food types, sensitivity to food textures, and unusual behaviors at mealtimes, are another overlapping representation in ASD and AN (110). Accordingly, children with ASD are more often hesitant to eat, and their food repertoire is limited (11, 111).
It is difficult to identify the complex relationships between ASD and EDs. It is possible that the overlap of symptoms makes AN and ASD share common underlying cognitive patterns and neuronal pathophysiology. Possible ways in which these traits might be interrelated between ASD and AN are described later. 1) Some of the shared clinical symptoms, such as social anxiety, might be secondary to both. 2) A fearful avoidant and obsessive personality structure (112–114) as well as insecure attachment patterns (115) are associated with an increased risk for AN. These traits are also frequent in ASD patients and might therefore favor the development of AN later. Interestingly, some studies have detected the persistence of cluster C personality disorders after remission from AN (116), meaning that potentially overlapping underlying personality traits may be present between EDs and ASD. However, longitudinal studies are needed to test the hypothesis that shared characteristics of personality functioning increase the risk for ASD as well as AN and form a common ground for both disturbances.
Overlap Between Eating Disorders and Attention-Deficit/Hyperactivity Disorder
To date, several studies have focused on the relationship between ADHD and EDs. In the reviewed studies, the prevalence rates for ADHD in EDs ranged between 1.6% (62) and 18.0% (59). Comorbid ADHD was more common in the AN-binge eating/purging subtype and BN than in the AN restrictive subtype. In comparison, the prevalence of ADHD in the general population is about 2.5% (117).
Studies that have focused on the prevalence of EDs in ADHD are heterogeneous, and they vary between no relationship between EDs and ADHD and 21.8% of females with ADHD and a lifetime ED history (55).
A previous systematic review found evidence of an association between childhood ADHD and the later development of either an ED or disordered eating. Support for this association was strongest for BN, multiple types of EDs clustered together, and disordered eating (65). Surman et al. (66) performed a systematic analysis on ADHD and BN with data from four case–control studies. Adult women with ADHD had significantly higher rates of BN than those without ADHD (12 vs. 3%, respectively, for one sample and 11 vs. 1%, respectively, for another). Nazar et al. (9) conducted a systematic review and a meta-analysis and found that patients with ADHD have a higher risk of comorbidity with an ED (the pooled odds ratio of diagnosing any ED in ADHD: 3.82), and people with an ED have higher levels of comorbidity with ADHD (the pooled odds ratio of diagnosing ADHD in ED participants: 2.57). The risk of comorbid ADHD in adults with BN was 5.71 (9).
It is difficult to compare previous studies because of the mixed composition of ED samples (AN, BN, and BED), the different age groups, and the various study designs (cross-sectional, retrospective, and prospective). For the analysis of EDs in ADHD samples, it is especially important to compare studies with participants of the same age group to avoid confounding effects when an ED is diagnosed later in development than is ADHD.
The core symptoms of ADHD, inattention, hyperactivity, and impulsivity are often present in EDs (118). Attentional impairment in AN and BN was detected in neuropsychological testing (119). These effects might either result from detrimental effects of malnutrition/starvation or be regarded as a predisposing trait, which increases the risk of developing an ED. Hyperactivity in the form of excessive exercising is common in AN and BN and is associated with compulsivity, perfectionism, and difficulties in affect regulation (120, 121). However, exercising is clearly related to attempting to influence weight and shape. The core features of BN are binge eating and purging behaviors, which can be described as impulsive (122). Previous investigations have shown increased impulsiveness and an impairment of inhibitory control to disease salient stimuli in patients with BN (123). In addition, studies have indicated that impulsivity in childhood, as opposed to inattentiveness and hyperactivity, is most predictive of adolescent BN pathology (57, 58). Apart from core ADHD symptoms, EDs and ADHD also share related symptoms, such as depression, anxiety, and low self-esteem (124, 125). Although there seems to be some overlap in clinical symptoms between EDs and ADHD, the relationship between these disorders needs further investigation. Longitudinal studies are needed to determine which factors precede the diseases (EDs and ADHD) and which should be regarded as their consequences.
Overlap Due to Shared Comorbidities?
When analyzing shared traits between EDs, ASD, and ADHD, it should be considered that additional shared common comorbidities might result in clinical and symptomatic overlap. Comorbidities are the rule rather the exception in patients with EDs (126), ASD (127, 128), and ADHD (129) alike. For example, anxiety disorders and mood disorders are frequently reported comorbidities of EDs (130, 131), ASD (132), and ADHD (129). In addition, impulse control problems were reported in patients with EDs (especially BN and BED) and patients with ADHD. “Multi-impulsive behaviors,” including alcohol abuse (133) and drug abuse (134), have been observed in a subgroup of ED patients (135) as well as in ADHD (129).
Because of the number of shared comorbidities, it might be difficult to completely determine their influence on symptom overlap between EDs, ASD, and ADHD and the prevalence rates of comorbidity. For future studies, it is therefore essential to carefully measure the rate of major overlapping comorbidities between EDs, ASD, and ADHD.
In addition, it is important to recognize that several symptoms in AN may be a consequence of malnutrition (137). Starvation may also lead to symptoms, such as irritability, depressed mood, decrease in self-initiated activity, and social introversion (138), which might also occur in ASD patients.
Eating Disorders as a Neurodevelopmental Disorder?
Per the DSM-5, NDDs are characterized by a manifestation of a set of stable perceptive, cognitive, emotional, and behavioral features early in development. NDDs frequently co-occur (1). A required criterion for an NDD is its manifestation early in development. Some previous studies have suggested that patients with EDs, especially those with AN, retrospectively report features that resemble features in NDDs, such as social difficulties in childhood (139). Social problems at age 8 were strongly predictive of EDs’ onset at age 14 (140). Additionally, two studies found an association between childhood impulsivity and the development of BN (57, 58). This may indicate that there are already predisposing traits earlier in childhood for the later development of an ED. However, it is less clear how specific these factors are for EDs. Furthermore, social problems in AN can be attributed to premorbid factors, such as insecure attachment patterns and harm avoidance (115, 126). By contrast, in ASD, they are due to impairment in communication, including the understanding of the conventions of social interaction.
Regarding the overrepresentation of ASD and ADHD in EDs, it could be discussed whether ASD and ADHD themselves might be predisposing factors for the development of EDs, which mainly occur during adolescence (2). Developmental changes, such as puberty, stressful events, and challenges, could trigger ED behaviors (141). Puberty could be considered an especially stressful phase of life for patients with ASD and ADHD. The additional stress of puberty for patients with ASD and ADHD (142, 143) may increase their vulnerability for the development of an ED. In addition, patients with NDDs have an elevated risk for other mental disorders beyond the ED spectrum (129, 132).
Therefore, it appears that NDDs may constitute a vulnerability factor for EDs. As such, EDs might be regarded one of many possible progressive (comorbid) “sequelae” of NDDs. An NDD is not a prerequisite for EDs, and EDs can also occur later in life; therefore, in our view, EDs, in general, should not be considered NDDs, but they could be regarded as a possible later aggravator of an NDD when symptoms evolve from the disease. EDs with a combined NDD may be considered special subgroups of EDs.
The literature points to considerable comorbidity rates and a symptomatic overlap between certain EDs, ASD, and ADHD. Nevertheless, the question of how much of the overlap is due to shared traits of the disorders per se and how much is due to either shared comorbid conditions or resembling traits has not been fully determined. There is a need for longitudinal studies to answer this question. Clinically, it is important to carefully conduct diagnostic procedures while considering the comorbidity rates and the overlap of symptoms. A thorough diagnostic workup should be conducted to develop individualized treatment strategies. In our view, EDs in general should not be regarded as NDDs. However, in a relevant subgroup of patients, they might be understood as a second-decade sequel of possibly subsyndromal NDDs, when EDs evolve from symptoms and/or psychodynamic problems that are linked to NDDs. EDs with combined NDDs may be considered special subgroups of EDs. To date, studies that have focused on the overlap between all three disorders are scarce. In the future, the risk of developing an ED in individuals who have been diagnosed with either ASD or ADHD should be systematically investigated, preferably in prospective studies. Case studies might add useful information to help derive hypotheses about factors that promote the development of a comorbid ED in adolescence. Prospective imaging studies in individuals at high risk for EDs (both with and without NDDs) could elicit more information about underlying common neurobiological structures. In addition, genetic studies could provide more information about possible overlapping genetic risk factors.
KN, SM, AZ, and LT wrote the manuscript. KN, VM, and DE performed literature search. KN, SM, AZ, LT, AJ, VM and DE were crucial involved in the theoretical discussion and the preparation of the manuscript. All authors read and approved the final version of the manuscript.
The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding program Open Access Publishing.
Conflict of Interest
LT: advisory boards, lectures, or travel grants within the last 4 years: Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen, and Cyberonics. DE was supported by the Berta-Ottenstein-Programme for Advanced Clinician Scientists, Faculty of Medicine, University of Freiburg.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
2. Herpertz-Dahlmann B. Adolescent eating disorders: update on definitions, symptomatology, epidemiology, and comorbidity. Child Adolesc Psychiatr Clin N Am (2015) 24:177–96. doi: 10.1016/j.chc.2014.08.003
3. Wentz E, Lacey JH, Waller G, Råstam M, Turk J, Gillberg C. Childhood onset neuropsychiatric disorders in adult eating disorder patients. A pilot study. Eur Child Adolesc Psychiatry (2005) 14:431–7. doi: 10.1007/s00787-005-0494-3
4. Dougherty CC, Evans DW, Myers SM, Moore GJ. Michael AM. A Comparison of structural brain imaging findings in autism spectrum disorder and attention-deficit hyperactivity disorder. Neuropsychol Rev (2016) 26:25–43. doi: 10.1007/s11065-015-9300-2
6. Hartley SL, Sikora DM. Which DSM-IV-TR criteria best differentiate high-functioning autism spectrum disorder from ADHD and anxiety disorders in older children? Autism Int J Res Pract (2009) 13:485–509. doi: 10.1177/1362361309335717
7. Tebartz van Elst L, Pick M, Biscaldi M, Fangmeier T, Riedel A. High-functioning autism spectrum disorder as a basic disorder in adult psychiatry and psychotherapy: psychopathological presentation, clinical relevance and therapeutic concepts. Eur Arch Psychiatry Clin Neurosci (2013) 263 Suppl 2:S189–196. doi: 10.1007/s00406-013-0459-3
8. Zucker NL, Losh M, Bulik CM, LaBar KS, Piven J, Pelphrey KA. Anorexia nervosa and autism spectrum disorders: guided investigation of social cognitive endophenotypes. Psychol Bull (2007) 133:976–1006. doi: 10.1037/0033-2909.133.6.976
9. Nazar BP, Bernardes C, Peachey G, Sergeant J, Mattos P, Treasure J. The risk of eating disorders comorbid with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Int J Eat Disord (2016) 49:1045–57. doi: 10.1002/eat.22643
11. Sharp WG, Berry RC, McCracken C, Nuhu NN, Marvel E, Saulnier CA, et al. Feeding problems and nutrient intake in children with autism spectrum disorders: a meta-analysis and comprehensive review of the literature. J Autism Dev Disord (2013) 43:2159–73. doi: 10.1007/s10803-013-1771-5
12. Karjalainen L, Gillberg C, Råstam M, Wentz E. Eating disorders and eating pathology in young adult and adult patients with ESSENCE. Compr Psychiatry (2016) 66:79–86. doi: 10.1016/j.comppsych.2015.12.009
13. Råstam M, Täljemark J, Tajnia A, Lundström S, Gustafsson P, Lichtenstein P, et al. Eating problems and overlap with ADHD and autism spectrum disorders in a nationwide twin study of 9- and 12-year-old children. Sci World J (2013) 2013:315429. doi: 10.1155/2013/315429
14. Lord C, Rutter M, Di Lavore PC, Risi S, Gotham K, Bishop SI. Autism diagnostic observation schedule, second edition (ADOS-2) manual (part 1) modules 1–4. Torrace: Western Psychological Services (2012).
16. Santosh PJ, Mandy WPL, Puura K, Kaartinen M, Warrington R, Skuse DH. The construction and validation of a short form of the developmental, diagnostic and dimensional interview. Eur Child Adolesc Psychiatry (2009) 18:521–4. doi: 10.1007/s00787-009-0004-0
17. Kaufman J, Birmaher B, Brent DA, Rao U, Ryan ND. Schedule for Affective Disorders and Schizophrenia for School Age Children, Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adoles Psychiatry (1997) 36:980–8.
18. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry (2000) 39:28–38. doi: 10.1097/00004583-200001000-00014
19. Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH, et al. [Wender Utah rating scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults]. Nervenarzt (2002) 73:830–8. doi: 10.1007/s00115-001-1215-x
20. Anckarsäter H, Hofvander B, Billstedt E, Gillberg IC, Gillberg C, Wentz E, et al. The sociocommunicative deficit subgroup in anorexia nervosa: autism spectrum disorders and neurocognition in a community-based, longitudinal study. Psychol Med (2012) 42:1957–67. doi: 10.1017/S0033291711002881
23. Koch SV, Larsen JT, Mouridsen SE, Bentz M, Petersen L, Bulik C, et al. Autism spectrum disorder in individuals with anorexia nervosa and in their first- and second-degree relatives: Danish nationwide register-based cohort-study. Br J Psychiatry J Ment Sci (2015) 206:401–7. doi: 10.1192/bjp.bp.114.153221
24. Nilsson EW, Gillberg C, Gillberg IC, Råstam M. Ten-year follow-up of adolescent-onset anorexia nervosa: personality disorders. J Am Acad Child Adolesc Psychiatry (1999) 38:1389–95. doi: 10.1097/00004583-199911000-00013
25. Pooni J, Ninteman A, Bryant-Waugh R, Nicholls D, Mandy W. Investigating autism spectrum disorder and autistic traits in early onset eating disorder. Int J Eat Disord (2012) 45:583–91. doi: 10.1002/eat.20980
26. Postorino V, Scahill L, De Peppo L, Fatta LM, Zanna V, Castiglioni MC, et al. Investigation of autism spectrum disorder and autistic traits in an adolescent sample with anorexia nervosa. J Autism Dev Disord (2017) 47:1051–61. doi: 10.1007/s10803-016-3023-y
28. Rhind C, Bonfioli E, Hibbs R, Goddard E, Macdonald P, Gowers S, et al. An examination of autism spectrum traits in adolescents with anorexia nervosa and their parents. Mol Autism (2014) 5:56. doi: 10.1186/2040-2392-5-56
29. Westwood H, Mandy W, Simic M, Tchanturia K. Assessing ASD in adolescent females with anorexia nervosa using clinical and developmental measures: a preliminary investigation. J Abnorm Child Psychol (2018) 46:183–92. doi: 10.1007/s10802-017-0301-x
31. Huke V, Turk J, Saeidi S, Kent A, Morgan JF. Autism spectrum disorders in eating disorder populations: a systematic review. Eur Eat Disord Rev J Eat Disord Assoc (2013) 21:345–51. doi: 10.1002/erv.2244
32. Westwood H, Eisler I, Mandy W, Leppanen J, Treasure J, Tchanturia K. Using the autism-spectrum quotient to measure autistic traits in anorexia nervosa: a systematic review and meta-analysis. J Autism Dev Disord (2016) 46:964–77. doi: 10.1007/s10803-015-2641-0
34. Bentz M, Jepsen JRM, Pedersen T, Bulik CM, Pedersen L, Pagsberg AK, et al. Impairment of social function in young females with recent-onset anorexia nervosa and recovered individuals. J Adolesc Health Off Publ Soc Adolesc Med (2017) 60:23–32. doi: 10.1016/j.jadohealth.2016.08.011
39. Fairburn CG, Beglin SJ. Assessment of eating disorders: interview or self-report questionnaire? Int J Eat Disord (1994) 16:363–70. doi: 10.1002/1098-108X(199412)16:4<363::AID-EAT2260160405>3.0.CO;2-%23
40. Ritvo RA, Ritvo ER, Guthrie D, Yuwiler A, Ritvo MJ, Weisbender L. A scale to assist the diagnosis of autism and Asperger’s disorder in adults (RAADS): a pilot study. J Autism Dev Disord (2008) 38:213–23. doi: 10.1007/s10803-007-0380-6
43. Goodman R, Ford T, Richards H, Gatward R, Meltzer H. The Development and Well-Being Assessment: description and initial validation of an integrated assessment of child and adolescent psychopathology. J Child Psychol Psychiatry (2000) 41:645–55. doi: 10.1017/S0021963099005909
46. Gillberg C, Gillberg C, Råstam M, Wentz E. The Asperger Syndrome (and high-functioning autism) Diagnostic Interview (ASDI): a preliminary study of a new structured clinical interview. Autism Int J Res Pract (2001) 5:57–66. doi: 10.1177/1362361301005001006
47. Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord (2001) 31:5–17.
49. Mirenda P, Smith IM, Vaillancourt T, Georgiades S, Duku E, Szatmari P, et al. Validating the Repetitive Behavior Scale-revised in young children with autism spectrum disorder. J Autism Dev Disord (2010) 40:1521–30. doi: 10.1007/s10803-010-1012-0
50. Bölte S, Rühl D, Schmötzer G, Poustka F. Diagnostisches Interview für Autismus - Revidiert. In Deutsche Fassung des Autism Diagnostic Interview - Revised (ADI-R) von Michael Rutter, Ann Le Couteur und Catherine Lord. Bern: Huber (2005).
51. Biederman J, Petty CR, Monuteaux MC, Fried R, Byrne D, Mirto T, et al. Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. Am J Psychiatry (2010) 167:409–17. doi: 10.1176/appi.ajp.2009.09050736
52. Biederman J, Ball SW, Monuteaux MC, Surman CB, Johnson JL, Zeitlin S. Are girls with ADHD at risk for eating disorders? Results from a controlled, five-year prospective study. J Dev Behav Pediatr JDBP (2007) 28:302–7. doi: 10.1097/DBP.0b013e3180327917
55. Edvinsson D, Lindström E, Bingefors K, Lewander T, Ekselius L. Gender differences of axis I and II comorbidity in subjects diagnosed with attention-deficit hyperactivity disorder as adults. Acta Neuropsychiatr (2013) 25:165–74. doi: 10.1111/j.1601-5215.2012.00682.x
56. Gorlin EI, Dalrymple K, Chelminski I, Zimmerman M. Diagnostic profiles of adult psychiatric outpatients with and without attention deficit hyperactivity disorder. Compr Psychiatry (2016) 70:90–7. doi: 10.1016/j.comppsych.2016.06.015
57. Mikami AY, Hinshaw SP, Arnold LE, Hoza B, Hechtman L, Newcorn JH, et al. Bulimia nervosa symptoms in the multimodal treatment study of children with ADHD. Int J Eat Disord (2010) 43:248–59. doi: 10.1002/eat.20692
58. Mikami AY, Hinshaw SP, Patterson KA, Lee JC. Eating pathology among adolescent girls with attention-deficit/hyperactivity disorder. J Abnorm Psychol (2008) 117:225–35. doi: 10.1037/0021-843X.117.1.225
59. Sala L, Martinotti G, Carenti ML, Romo L, Oumaya M, Pham-Scottez A, et al. Attention-deficit/hyperactivity disorder symptoms and psychological comorbidity in eating disorder patients. Eat Weight Disord EWD (2018) 23(4):513–9. doi: 10.1007/s40519-017-0395-8
60. Seitz J, Kahraman-Lanzerath B, Legenbauer T, Sarrar L, Herpertz S, Salbach-Andrae H, et al. The role of impulsivity, inattention and comorbid ADHD in patients with bulimia nervosa. PloS One (2013) 8:e63891. doi: 10.1371/journal.pone.0063891
61. Sobanski E, Brüggemann D, Alm B, Kern S, Deschner M, Schubert T, et al. Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci (2007) 257:371–7. doi: 10.1007/s00406-007-0712-8
64. Yoshimasu K, Barbaresi WJ, Colligan RC, Voigt RG, Killian JM, Weaver AL, et al. Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study. J Child Psychol Psychiatry (2012) 53:1036–43. doi: 10.1111/j.1469-7610.2012.02567.x
65. Levin RL, Rawana JS. Attention-deficit/hyperactivity disorder and eating disorders across the lifespan: a systematic review of the literature. Clin Psychol Rev (2016) 50:22–36. doi: 10.1016/j.cpr.2016.09.010
66. Surman CBH, Randall ET, Biederman J. Association between attention-deficit/hyperactivity disorder and bulimia nervosa: analysis of 4 case-control studies. J Clin Psychiatry (2006) 67:351–4. doi: 10.4088/JCP.v67n0303
67. Gau SS-F, Ni H-C, Shang C-Y, Soong W-T, Wu Y-Y, Lin L-Y, et al. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder. Aust N Z J Psychiatry (2010) 44:135–43. doi: 10.3109/00048670903282733
68. Ghanizadeh A, Mohammadi MR, Moini R. Comorbidity of psychiatric disorders and parental psychiatric disorders in a sample of Iranian children with ADHD. J Atten Disord (2008) 12:149–55. doi: 10.1177/1087054708314601
69. Kessler RC, Adler LA, Berglund P, Green JG, McLaughlin KA, Fayyad J, et al. The effects of temporally secondary co-morbid mental disorders on the associations of DSM-IV ADHD with adverse outcomes in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A). Psychol Med (2014) 44:1779–92. doi: 10.1017/S0033291713002419
70. Reinblatt SP, Leoutsakos J-MS, Mahone EM, Forrester S, Wilcox HC, Riddle MA. Association between binge eating and attention-deficit/hyperactivity disorder in two pediatric community mental health clinics. Int J Eat Disord (2015) 48:505–11. doi: 10.1002/eat.22342
71. Yilmaz Z, Kaplan AS, Zai CC, Levitan RD, Kennedy JL. COMT Val158Met variant and functional haplotypes associated with childhood ADHD history in women with bulimia nervosa. Prog Neuropsychopharmacol Biol Psychiatry (2011) 35:948–52. doi: 10.1016/j.pnpbp.2011.01.012
72. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry (2002) 159:36–42. doi: 10.1176/appi.ajp.159.1.36
73. Welch E, Jangmo A, Thornton LM, Norring C, von Hausswolff-Juhlin Y, Herman BK, et al. Treatment-seeking patients with binge-eating disorder in the Swedish national registers: clinical course and psychiatric comorbidity. BMC Psychiatry (2016) 16:163. doi: 10.1186/s12888-016-0840-7
74. Biederman J, Faraone SV, Monuteaux MC, Bober M, Cadogen E. Gender effects on attention-deficit/hyperactivity disorder in adults, revisited. Biol Psychiatry (2004) 55:692–700. doi: 10.1016/j.biopsych.2003.12.003
75. Biederman J, Faraone SV, Spencer T, Wilens T, Mick E, Lapey KA. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res (1994) 53:13–29. doi: 10.1016/0165-1781(94)90092-2
76. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry (1993) 150:885–90. doi: 10.1176/ajp.150.6.885
79. Garner DM, Olmsted MP, Polivy J. Development and validation of a multidimensional eating disorder inventory for anorexia nervosa and bulimia. Int J Eat Disord (1983) 2:15–34. doi: 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6
81. Kessler RC, Adler LA, Gruber MJ, Sarawate CA, Spencer T, Van Brunt DL. Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res (2007) 16:52–65. doi: 10.1002/mpr.208
83. Rösler M, Retz W, Retz-Junginger P, Stieglitz RD, Kessler H, Reimherr F, et al. [Attention deficit hyperactivity disorder in adults. Benchmarking diagnosis using the Wender-Reimherr adult rating scale]. Nervenarzt (2008) 79:320–7. doi: 10.1007/s00115-007-2375-0
84. Rösler M, Retz W, Thome J, Schneider M, Stieglitz R-D, Falkai P. Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci (2006) 256 Suppl 1:i3–11. doi: 10.1007/s00406-006-1001-7
86. Fichter M, Quadflieg N. The structured interview for anorexic and bulimic disorders for DSM-IV and ICD-10 (SIAB-EX): reliability and validity. Eur Psychiatry J Assoc Eur Psychiatr (2001) 16:38–48. doi: 10.1016/S0924-9338(00)00534-4
88. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 59 Suppl 20:22–33;quiz 34-57.
89. Fichter MM, Elaton M, Engel K, Meyer AE, Mall H, Poustka F. Structured Interview for Anorexia and Bulimia Nervosa (SIAB): Development of a new instrument for the assessment of eating disorders. Int J Eat Disord (1991) 10:571–92. doi: 10.1002/1098-108X(199109)10:5<571::AID-EAT2260100510>3.0.CO;2-J
90. Shapiro JR, Woolson SL, Hamer RM, Kalarchian MA, Marcus MD, Bulik CM. Evaluating binge eating disorder in children: development of the children’s binge eating disorder scale (C-BEDS). Int J Eat Disord (2007) 40:82–9. doi: 10.1002/eat.20318
94. Godart NT, Perdereau F, Rein Z, Berthoz S, Wallier J, Jeammet P, et al. Comorbidity studies of eating disorders and mood disorders. Critical review of the literature. J Affect Disord (2007) 97:37–49. doi: 10.1016/j.jad.2006.06.023
95. Serpell L, Livingstone A, Neiderman M, Lask B. Anorexia nervosa: obsessive-compulsive disorder, obsessive-compulsive personality disorder, or neither? Clin Psychol Rev (2002) 22:647–69. doi: 10.1016/S0272-7358(01)00112-X
96. Keski-Rahkonen A, Mustelin L. Epidemiology of eating disorders in Europe: prevalence, incidence, comorbidity, course, consequences, and risk factors. Curr Opin Psychiatry (2016) 29:340–5. doi: 10.1097/YCO.0000000000000278
98. Smith KE, Mason TB, Johnson JS, Lavender JM, Wonderlich SA. A systematic review of reviews of neurocognitive functioning in eating disorders: The state-of-the-literature and future directions. Int J Eat Disord (2018) 51(8):798–821. doi: 10.1002/eat.22929
99. Lang K, Stahl D, Espie J, Treasure J, Tchanturia K. Set shifting in children and adolescents with anorexia nervosa: an exploratory systematic review and meta-analysis. Int J Eat Disord (2014) 47:394–9. doi: 10.1002/eat.22235
100. Lopez C, Tchanturia K, Stahl D, Booth R, Holliday J, Treasure J. An examination of the concept of central coherence in women with anorexia nervosa. Int J Eat Disord (2008) 41:143–52. doi: 10.1002/eat.20478
102. Roberts ME, Tchanturia K, Stahl D, Southgate L, Treasure J. A systematic review and meta-analysis of set-shifting ability in eating disorders. Psychol Med (2007) 37:1075–84. doi: 10.1017/S0033291707009877
104. Oldershaw A, Hambrook D, Tchanturia K, Treasure J, Schmidt U. Emotional theory of mind and emotional awareness in recovered anorexia nervosa patients. Psychosom Med (2010) 72:73–9. doi: 10.1097/PSY.0b013e3181c6c7ca
105. Peñas-Lledó E, Jiménez-Murcia S, Granero R, Penelo E, Agüera Z, Alvarez-Moya E, et al. Specific eating disorder clusters based on social anxiety and novelty seeking. J Anxiety Disord (2010) 24:767–73. doi: 10.1016/j.janxdis.2010.05.010
106. White SW, Kreiser NL, Pugliese C, Scarpa A. Social anxiety mediates the effect of autism spectrum disorder characteristics on hostility in young adults. Autism Int J Res Pract (2012) 16:453–64. doi: 10.1177/1362361311431951
107. Chevallier C, Grèzes J, Molesworth C, Berthoz S, Happé F. Brief report: selective social anhedonia in high functioning autism. J Autism Dev Disord (2012) 42:1504–9. doi: 10.1007/s10803-011-1364-0
111. Bandini LG, Anderson SE, Curtin C, Cermak S, Evans EW, Scampini R, et al. Food selectivity in children with autism spectrum disorders and typically developing children. J Pediatr (2010) 157:259–64. doi: 10.1016/j.jpeds.2010.02.013
112. Anderluh MB, Tchanturia K, Rabe-Hesketh S, Treasure J. Childhood obsessive-compulsive personality traits in adult women with eating disorders: defining a broader eating disorder phenotype. Am J Psychiatry (2003) 160:242–7. doi: 10.1176/appi.ajp.160.2.242
114. Lilenfeld LRR, Wonderlich S, Riso LP, Crosby R, Mitchell J. Eating disorders and personality: a methodological and empirical review. Clin Psychol Rev (2006) 26:299–320. doi: 10.1016/j.cpr.2005.10.003
115. Jewell T, Collyer H, Gardner T, Tchanturia K, Simic M, Fonagy P, et al. Attachment and mentalization and their association with child and adolescent eating pathology: A systematic review. Int J Eat Disord (2016) 49:354–73. doi: 10.1002/eat.22473
116. Matsunaga H, Kaye WH, McConaha C, Plotnicov K, Pollice C, Rao R. Personality disorders among subjects recovered from eating disorders. Int J Eat Disord (2000) 27:353–7. doi: 10.1002/(SICI)1098-108X(200004)27:3<353::AID-EAT14>3.0.CO;2-E
117. Katzman MA, Bilkey TS, Chokka PR, Fallu A, Klassen LJ. Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry (2017) 17(1):302. doi: 10.1186/s12888-017-1463-3
121. Shroff H, Reba L, Thornton LM, Tozzi F, Klump KL, Berrettini WH, et al. Features associated with excessive exercise in women with eating disorders. Int J Eat Disord (2006) 39:454–61. doi: 10.1002/eat.20247
122. Stulz N, Hepp U, Gächter C, Martin-Soelch C, Spindler A, Milos G. The severity of ADHD and eating disorder symptoms: a correlational study. BMC Psychiatry (2013) 13:44. doi: 10.1186/1471-244X-13-44
123. Wu M, Hartmann M, Skunde M, Herzog W, Friederich H-C. Inhibitory control in bulimic-type eating disorders: a systematic review and meta-analysis. PloS One (2013) 8:e83412. doi: 10.1371/journal.pone.0083412
125. Svedlund NE, Norring C, Ginsberg Y, von Hausswolff-Juhlin Y. Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) among adult eating disorder patients. BMC Psychiatry (2017) 17:19. doi: 10.1186/s12888-016-1093-1
127. Hofvander B, Delorme R, Chaste P, Nydén A, Wentz E, Ståhlberg O, et al. Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry (2009) 9:35. doi: 10.1186/1471-244X-9-35
128. Riedel A, Schröck C, Ebert D, Fangmeier T, Bubl E, Tebartz van Elst L. [Well Educated Unemployed–On Education, Employment and Comorbidities in Adults with High-Functioning Autism Spectrum Disorders in Germany]. Psychiatr Prax (2016) 43:38–44. doi: 10.1055/s-0034-1387494
129. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry (1991) 148:564–77. doi: 10.1176/ajp.148.5.564
131. Mangweth B, Hudson JI, Pope HG, Hausmann A, De Col C, Laird NM, et al. Family study of the aggregation of eating disorders and mood disorders. Psychol Med (2003) 33:1319–23. doi: 10.1017/S0033291703008250
132. Mukaddes NM, Hergüner S, Tanidir C. Psychiatric disorders in individuals with high-functioning autism and Asperger’s disorder: similarities and differences. World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry (2010) 11:964–71. doi: 10.3109/15622975.2010.507785
134. Calero-Elvira A, Krug I, Davis K, López C, Fernández-Aranda F, Treasure J. Meta-analysis on drugs in people with eating disorders. Eur Eat Disord Rev J Eat Disord Assoc (2009) 17:243–59. doi: 10.1002/erv.936
136. Jacob S, Landeros-Weisenberger A, Leckman JF. Autism spectrum and obsessive-compulsive disorders: OC behaviors, phenotypes and genetics. Autism Res Off J Int Soc Autism Res (2009) 2:293–311. doi: 10.1002/aur.108
139. Krug I, Penelo E, Fernandez-Aranda F, Anderluh M, Bellodi L, Cellini E, et al. Low social interactions in eating disorder patients in childhood and adulthood: a multi-centre European case control study. J Health Psychol (2013) 18:26–37. doi: 10.1177/1359105311435946
140. Allen KL, Byrne SM, Forbes D, Oddy WH. Risk factors for full- and partial-syndrome early adolescent eating disorders: a population-based pregnancy cohort study. J Am Acad Child Adolesc Psychiatry (2009) 48:800–9. doi: 10.1097/CHI.0b013e3181a8136d
Keywords: anorexia nervosa, bulimia nervosa, binge eating disorder, autism spectrum disorder, attention-deficit/hyperactivity disorder
Citation: Nickel K, Maier S, Endres D, Joos A, Maier V, Tebartz van Elst L and Zeeck A (2019) Systematic Review: Overlap Between Eating, Autism Spectrum, and Attention-Deficit/Hyperactivity Disorder. Front. Psychiatry 10:708. doi: 10.3389/fpsyt.2019.00708
Received: 15 September 2018; Accepted: 03 September 2019;
Published: 10 October 2019.
Edited by:Kerim M. Munir, Harvard Medical School, United States
Reviewed by:Lin Sørensen, University of Bergen, Norway
Joe J. Simon, Heidelberg University, Germany
Tobias Bracht, University of Bern, Switzerland
Copyright © 2019 Nickel, Maier, Endres, Joos, Maier, Tebartz van Elst and Zeeck. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kathrin Nickel, email@example.com
†These authors have contributed equally to this work
‡These senior authors have contributed equally to this work